Bicycle riding has no important impact on total and free prostate-specific antigen serum levels in older men

Urology

Volumn 61, Issue 6, 2003, Pages 1177-1180

  Luboldt, Hans Joachim ^a   Peck, Klaus D ^b   Oberpenning, Frank ^b   Schmid, Hans Peter ^b   Luboldt, Wolfgang ^b   Semjonow, Axel ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BICYCLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CANCER SCREENING; CYCLING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERINEUM; PHYSICAL ACTIVITY; PRESSURE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; WILCOXON SIGNED RANKS TEST;

EID: 0037940216     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00007-4     Document Type: Article

References (22)

1. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease a prospective multicenter clinical trial . JAMA. 279:1998;1542-1547.
2. Prestigiacomo A.F., Stamey T.A. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng/ml range in male volunteers. J Urol. 155:1996;1977-1980.
3. Nadler R.B., Humphrey P.A., Smith D.S., et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 154:1995;407-413.
4. Ornstein D.K., Smith D.S., Humphrey P.A., et al. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol. 159:1998;1234-1237.
5. Oesterling J.E., Rice D.C., Glenski W.J., et al. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology. 42:1993;276-282.
6. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916.
7. Leventhal E.K., Rozanski T.A., Morey A.F., et al. The effects of exercise and activity on serum prostate specific antigen levels. J Urol. 150:1993;893-894.
8. Cevik I., Turkeri L.N., Ozveri H., et al. Short-term effect of digital rectal examination on serum prostate-specific antigen levels a prospective study . Eur Urol. 29:1996;403-406.
9. Bossens M.M., Van Straalen J.P., De Reijke T.M., et al. Kinetics of prostate-specific antigen after manipulation of the prostate. Eur J Cancer. 31A:1995;682-685.
10. Crawford E.D., Schutz M.J., Clejan S., et al. The effect of digital rectal examination on prostate-specific antigen levels. JAMA. 267:1992;2227-2228.
11. Oremek G.M., Seiffert U.B. Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clin Chem. 42:1996;691-695.
12. Crawford E.D. III, Mackenzie S.H., Safford H.R., et al. The effect of bicycle riding on serum prostate specific antigen levels. J Urol. 156:1996;103-105.
13. Mebust WKR, Bosch R, Donovan J, et al: Symptom evaluation, quality of life and sexuality, in Cockett S, Khoury Y, Aso C, et al (Eds): The 2nd Consultation on Benign Prostatic Hyperplasia (BPH). Chanel Islands, Paris Scientific Communication International Ltd., 1993, pp 129-149.
14. 1-antichymotrypsin. J Urol. 162:1999;897-901.
15. van Straalen J.P., Bossens M.M., de Reijke T.M., et al. Biological half-life of prostate-specific antigen after radical prostatectomy. Eur J Clin Chem Clin Biochem. 32:1994;53-55.
16. Semjonow A., Hamm M., Rathert P. Elimination kinetics of prostate-specific antigen serum and urine. Int J Biol Markers. 9:1994;15-20.
17. Brandle E., Hautmann O., Bachem M., et al. Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy - a critical assessment. Urology. 53:1999;722-730.
18. Oesterling J.E. Prostate specific antigen a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate . J Urol. 145:1991;907-923.
19. Komatsu K., Wehner N., Prestigiacomo A.F., et al. Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology. 47:1996;343-346.
20. Lujan M., Paez A., Sanchez E., et al. Prostate specific antigen variation in patients without clinically evident prostate cancer. J Urol. 162:1999;1311-1313.
21. Collins G.N., Martin P.J., Wynn-Davies A., et al. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice. J Urol. 157:1997;1744-1747.
22. Elgamal A.A., Baert L. Re: the free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. J Urol. 159:1998;994-995.